High expression of MYL9 is known to be a tumor and metastasis promoter for several cancer subtypes, as found by quantifying metastatic nodules on livers and lymphatic metastases in CRC and non-small-cell lung cancer [15,23]. Here, MYL9 is linked to neoplasm.